Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank71
3Y CAGR+25.7%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
+25.7%/yr
vs -44.3%/yr prior
Acceleration
+70.0pp
Accelerating
Percentile
P71
Within normal range
vs 3Y Ago
2x
Strong expansion
Streak
5 yr
Consecutive growthCompressed
PeriodValueYoY Change
20250.19+31.0%
20240.15+11.9%
20230.13+35.5%
20220.10+16.6%
20210.08+151.4%
2020-0.16-101.1%
201915.23+1423.4%
20181.00-